A detailed history of Interchange Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 19,766 shares of PFE stock, worth $521,031. This represents 0.21% of its overall portfolio holdings.

Number of Shares
19,766
Previous 20,705 4.54%
Holding current value
$521,031
Previous $579,000 1.21%
% of portfolio
0.21%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$27.7 - $31.39 $26,010 - $29,475
-939 Reduced 4.54%
19,766 $572,000
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $523,008 - $612,868
20,705 New
20,705 $579,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $237,163 - $274,393
-6,566 Reduced 46.59%
7,527 $276,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $371,093 - $483,108
9,421 Added 201.65%
14,093 $574,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $57,406 - $74,937
-1,375 Reduced 22.74%
4,672 $239,000
Q3 2022

Nov 07, 2022

SELL
$43.76 - $53.42 $8,752 - $10,684
-200 Reduced 3.2%
6,047 $264,000
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $12,470 - $14,785
-268 Reduced 4.11%
6,247 $327,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $27,495 - $34,070
-601 Reduced 8.45%
6,515 $337,000
Q4 2021

Feb 04, 2022

BUY
$41.32 - $61.25 $83,301 - $123,480
2,016 Added 39.53%
7,116 $420,000
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $34,343 - $44,117
-875 Reduced 14.64%
5,100 $219,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $307,210 - $348,017
-8,555 Reduced 58.88%
5,975 $233,000
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $103,316 - $116,520
-3,085 Reduced 17.51%
14,530 $581,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $589,574 - $749,694
17,615 New
17,615 $648,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.